This very large cohort study demonstrated an association between use of intermediate-duration NMBD and risk of postoperative desaturation and reintubation requiring ICU admission, and a similar association with these outcomes and neostigmine reversal.

Qualitative neuromuscular monitoring did not reduce this risk.

Study population was all patients at Massachusetts General Hospital undergoing general anaesthesia including a muscle relaxant over a 4 year period, and who were extubated at the end of the procedure.

summary

• Martina Grosse-Sundrup, Justin P Henneman, Warren S Sandberg, Brian T Bateman, Jose Villa Uribe, Nicole Thuy Nguyen, Jesse M Ehrenfeld, Elizabeth A Martinez, Tobias Kurth, and Matthias Eikermann.
• Department of Anaesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, 02114, USA.
• BMJ. 2012 Jan 1;345:e6329.

ObjectiveTo determine whether use of intermediate acting neuromuscular blocking agents during general anesthesia increases the incidence of postoperative respiratory complications.DesignProspective, propensity score matched cohort study.SettingGeneral teaching hospital in Boston, Massachusetts, United States, 2006-10.Participants18,579 surgical patients who received intermediate acting neuromuscular blocking agents during surgery were matched by propensity score to 18,579 reference patients who did not receive such agents.Main Outcome MeasuresThe main outcome measures were oxygen desaturation after extubation (hemoglobin oxygen saturation <90% with a decrease in oxygen saturation after extubation of >3%) and reintubations requiring unplanned admission to an intensive care unit within seven days of surgery. We also evaluated effects on these outcome variables of qualitative monitoring of neuromuscular transmission (train-of-four ratio) and reversal of neuromuscular blockade with neostigmine to prevent residual postoperative neuromuscular blockade.ResultsThe use of intermediate acting neuromuscular blocking agents was associated with an increased risk of postoperative desaturation less than 90% after extubation (odds ratio 1.36, 95% confidence interval 1.23 to 1.51) and reintubation requiring unplanned admission to an intensive care unit (1.40, 1.09 to 1.80). Qualitative monitoring of neuromuscular transmission did not decrease this risk and neostigmine reversal increased the risk of postoperative desaturation less than 90% (1.32, 1.20 to 1.46) and reintubation (1.76, 1.38 to 2.26).ConclusionThe use of intermediate acting neuromuscular blocking agents during anesthesia was associated with an increased risk of clinically meaningful respiratory complications. Our data suggest that the strategies used in our trial to prevent residual postoperative neuromuscular blockade should be revisited.

This article appears in the collection: Neuromuscular myths: the lies we tell ourselves.

38 keywords...

hide…